Prostatic Disease
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (NCT05150236) | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 2022-04-29 |
| 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical (NCT04831307) | British Columbia Cancer Agency | 2021-08-30 |
| High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy (NCT04461509) | Alessandro D'Agnolo | 2021-04-06 |
| Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA (NCT04760483) | Urological Research Network, LLC | 2020-11-20 |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) (NCT04249947) | Poseida Therapeutics, Inc. | 2020-02-28 |
| Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment (NCT00210249) | Institut Bergonié | 2002-09-01 |
Track Prostatic Disease automatically
Every clearance here is in the API, with alerts when new ones post.